Acquired antithrombin III deficiency—rationale for replacement therapy. Introduction and overview—What are the questions?
An overview of the mechanism of action of antithrombin and its inherited deficiency states
Antithrombin III deficiency in neonatal respiratory distress syndrome
The hypercoagulable state in cancer patients : evidence for impaired thrombin inhibitions
Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukaemia
Antithrombin III replacement in animal models of acquired antithrombin III deficiency
Strategies for inhibiting the effects of thrombin
Panel Discussion : Rationale for replacement therapy for acquired antithrombin III deficiency